Phase II study of cyclophosphamide, vincristine and D.T.I.C. +/- B.C.G. in the treatment of malignant melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/6958237

Download in:

View as

General Info

PMID
6958237